Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-8256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-8262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-8206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-205 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2016-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018506405-A |
titleOfInvention |
Pharmaceutical composition and device for pain treatment |
abstract |
The present invention relates to a nasal cavity of at least one active ingredient belonging to active ingredient group DR having at least a respiratory depression side effect and at least one active ingredient belonging to active ingredient group ADR that resists respiratory depression that can be induced by the active ingredient of DR group. It relates to an internal continuous administration system. The present invention further relates to a portable medical device for intranasal continuous administration incorporating an intranasal administration system according to the principles of the present invention. [Selection] Figure 1 |
priorityDate |
2015-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |